RPH3A
Basic information
Region (hg38): 12:112570380-112898881
Links
Phenotypes
GenCC
Source:
- congenital myasthenic syndrome (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RPH3A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 38 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 1 | 0 | 38 | 2 | 2 |
Highest pathogenic variant AF is 0.0000131
Variants in RPH3A
This is a list of pathogenic ClinVar variants found in the RPH3A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-112828349-A-G | Inborn genetic diseases | Uncertain significance (Mar 20, 2023) | ||
12-112828352-C-G | Inborn genetic diseases | Uncertain significance (Apr 08, 2024) | ||
12-112828353-G-T | Inborn genetic diseases | Uncertain significance (May 13, 2024) | ||
12-112828373-C-T | Inborn genetic diseases | Uncertain significance (May 31, 2022) | ||
12-112847722-C-A | Inborn genetic diseases | Uncertain significance (Apr 07, 2022) | ||
12-112847727-G-T | Inborn genetic diseases | Uncertain significance (Jan 05, 2022) | ||
12-112847746-G-A | Inborn genetic diseases | Uncertain significance (Oct 12, 2022) | ||
12-112847764-C-G | Inborn genetic diseases | Uncertain significance (Jan 23, 2024) | ||
12-112847790-A-G | Inborn genetic diseases | Uncertain significance (Jan 20, 2023) | ||
12-112847841-G-A | not specified | Uncertain significance (Mar 04, 2019) | ||
12-112865451-G-A | Inborn genetic diseases | Uncertain significance (Oct 03, 2023) | ||
12-112865531-G-T | Inborn genetic diseases | Uncertain significance (Aug 02, 2023) | ||
12-112866759-C-A | Inborn genetic diseases | Uncertain significance (May 13, 2024) | ||
12-112866785-C-A | Inborn genetic diseases | Uncertain significance (Oct 29, 2021) | ||
12-112866796-C-G | Inborn genetic diseases | Uncertain significance (Apr 07, 2023) | ||
12-112868439-C-T | Inborn genetic diseases | Uncertain significance (Dec 13, 2023) | ||
12-112868481-C-T | Inborn genetic diseases | Uncertain significance (Aug 02, 2023) | ||
12-112868571-C-A | Inborn genetic diseases | Uncertain significance (Dec 27, 2022) | ||
12-112868580-C-T | Inborn genetic diseases | Uncertain significance (Jan 03, 2024) | ||
12-112868587-C-T | Inborn genetic diseases | Uncertain significance (Jun 24, 2022) | ||
12-112868593-G-A | Benign (Dec 31, 2019) | |||
12-112869751-T-G | RPH3A-related condition | Likely benign (Jun 21, 2024) | ||
12-112869783-C-T | Inborn genetic diseases | Uncertain significance (Jan 03, 2024) | ||
12-112869786-G-A | Inborn genetic diseases | Uncertain significance (Oct 03, 2022) | ||
12-112869916-G-C | Inborn genetic diseases | Uncertain significance (May 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RPH3A | protein_coding | protein_coding | ENST00000389385 | 20 | 328503 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00166 | 0.998 | 125731 | 0 | 16 | 125747 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.31 | 350 | 426 | 0.821 | 0.0000253 | 4532 |
Missense in Polyphen | 89 | 147.28 | 0.60429 | 1564 | ||
Synonymous | 0.172 | 152 | 155 | 0.982 | 0.00000922 | 1317 |
Loss of Function | 4.39 | 14 | 46.2 | 0.303 | 0.00000268 | 479 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000119 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000621 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000165 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Protein transport. Probably involved with Ras-related protein Rab-3A in synaptic vesicle traffic and/or synaptic vesicle fusion. Could play a role in neurotransmitter release by regulating membrane flow in the nerve terminal (By similarity). {ECO:0000250}.;
- Pathway
- Deregulation of Rab and Rab Effector Genes in Bladder Cancer
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.527
- rvis_EVS
- -1.48
- rvis_percentile_EVS
- 3.66
Haploinsufficiency Scores
- pHI
- 0.302
- hipred
- Y
- hipred_score
- 0.597
- ghis
- 0.600
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.699
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rph3a
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- intracellular protein transport
- Cellular component
- Golgi apparatus;cytosol;synaptic vesicle;extrinsic component of membrane;cell junction;secretory granule;synaptic vesicle membrane;protein-containing complex;neuron projection;synapse
- Molecular function
- calcium ion binding;protein binding;calcium-dependent phospholipid binding;phosphatidylinositol-4,5-bisphosphate binding;zinc ion binding;selenium binding;Rab GTPase binding;phosphate ion binding;protein-containing complex binding;inositol 1,4,5 trisphosphate binding;phosphatidylinositol phosphate binding